G490-0537 Screening compound: N-(3,4-difluorophenyl)-2-[2-(4-fluorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-en-8-yl]acetamide

G490-0537 Screening compound: N-(3,4-difluorophenyl)-2-[2-(4-fluorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-en-8-yl]acetamide
G490-0537 Screening compound: N-(3,4-difluorophenyl)-2-[2-(4-fluorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-en-8-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G490-0537
N-(3,4-difluorophenyl)-2-[2-(4-fluorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-en-8-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G490-0537

Molecular Formula

C21H19F3N4O2 (C21 H19 F3 N4 O2)

Compound Name

N-(3,4-difluorophenyl)-2-[2-(4-fluorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-en-8-yl]acetamide

IUPAC name

N-(34-difluorophenyl)-2-[2-(4-fluorophenyl)-3-oxo-148-triazaspiro[4.5]dec-1-en-8-yl]acetamide

SMILES

O=C(CN(CC1)CCC1(NC1=O)N=C1c(cc1)ccc1F)Nc(cc1)cc(F)c1F

InChI

InChI=1S/C21H19F3N4O2/c22-14-3-1-13(2-4-14)19-20(30)27-21(26-19)7-9-28(10-8-21)12-18(29)25-15-5-6-16(23)17(24)11-15/h1-6,11H,7-10,12H2,(H,25,29)(H,27,30)

InChI Key

RCIDICDCKHQZKQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15014615

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

416.4

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.145

Distribution Coefficient, logD

3.096

Water Solubility, LogSw

-3.35

Polar Surface Area

60.471

Acid Dissociation Constant (pKa)

8.90

Base Dissociation Constant (pKb)

6.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

G490-0537 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G490-0537 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G490-0537?
Check Price and Availability of G490-0537, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G490-0537 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G490-0537
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G490-0537
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G490-0537 available by request